Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem Cells  by Chapman, Karen M. et al.
ReportTargeted Germline Modifications in Rats Using
CRISPR/Cas9 and Spermatogonial Stem CellsGraphical AbstractHighlightsd CRISPR/Cas9 targets heritable germline modifications in
donor spermatogonia
d Direct germline editing eliminates CRISPR/Cas9-catalyzed
animal mosaicism
d In vitro and in vivo recessive genetic screens for
spermatogenesisChapman et al., 2015, Cell Reports 10, 1828–1835
March 24, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.02.040Authors
Karen M. Chapman,
Gerardo A. Medrano, ..., Carole Ober,
F. Kent Hamra
Correspondence
kent.hamra@utsouthwestern.edu
In Brief
Chapman et al. now use CRISPR/Cas9 to
target heritable mutations within
spermatogonia, fully functional rat
germline stem cells. Clonally enriched
target alleles were vertically transmitted
from donor spermatogonia to rat
progeny. Direct germline editing in
spermatogonia prevented CRISPR/Cas9-
catalyzed animal mosaicism by avoiding
totipotent and pluripotent states of
embryogenesis.
Cell Reports
ReportTargeted Germline Modifications
in Rats Using CRISPR/Cas9
and Spermatogonial Stem Cells
Karen M. Chapman,1 Gerardo A. Medrano,1 Priscilla Jaichander,1 Jaideep Chaudhary,1 Alexandra E. Waits,1
Marcelo A. Nobrega,3 James M. Hotaling,4 Carole Ober,3 and F. Kent Hamra1,2,*
1Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
2Cecil H. & Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
3Department of Human Genetics, University of Chicago, Chicago, IL 60637, USA
4Department of Surgery (Urology), University of Utah School of Medicine, Salt Lake City, UT 84134, USA
*Correspondence: kent.hamra@utsouthwestern.edu
http://dx.doi.org/10.1016/j.celrep.2015.02.040
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARY
Organisms with targeted genomic modifications are
efficiently produced by gene editing in embryos us-
ing CRISPR/Cas9 RNA-guided DNA endonuclease.
Here, to facilitate germline editing in rats, we used
CRISPR/Cas9 to catalyze targeted genomic muta-
tions in rat spermatogonial stem cell cultures.
CRISPR/Cas9-modified spermatogonia regenerated
spermatogenesis and displayed long-term sperm-
forming potential following transplantation into rat
testes. Targeted germline mutations in Epsti1 and
Erbb3 were vertically transmitted from recipients
to exclusively generate ‘‘pure,’’ non-mosaic mutant
progeny. Epsti1 mutant rats were produced with or
without genetic selection of donor spermatogonia.
Monoclonal enrichment of Erbb3 null germlines un-
masked recessive spermatogenesis defects in cul-
ture that were buffered in recipients, yielding mutant
progeny isogenic at targeted alleles. Thus, sper-
matogonial gene editing with CRISPR/Cas9 provided
a platform for generating targeted germline muta-
tions in rats and for studying spermatogenesis.
INTRODUCTION
CRISPR/Cas9 RNA-guided DNA endonuclease technology is
being widely utilized to generate targeted genomic mutations
in diverse cell types and organisms to study their biological pro-
cesses (Harrison et al., 2014). Gene editing with CRISPR/Cas9 in
mammals yields high rates of donor-embryo-derived progeny
harboring targeted gene mutations in rodents, pigs, goats, and
monkeys (Hai et al., 2014; Li et al., 2013; Ni et al., 2014; Niu
et al., 2014; Wang et al., 2013; Yang et al., 2013). Mutant rodents
can be produced in <1 month upon injection of constructs ex-
pressing gRNAs andCas9 that direct cleavage of target gene se-
quences in donor zygotes (Li et al., 2013;Wang et al., 2013; Yang
et al., 2013). CRISPR/Cas9 is so efficient, both alleles for multiple1828 Cell Reports 10, 1828–1835, March 24, 2015 ª2015 The Authortarget genes can be disrupted in animals produced by co-inject-
ing zygotes with respective gRNAs (Li et al., 2014; Ma et al.,
2014; Ni et al., 2014; Wang et al., 2013; Yang et al., 2013).
CRISPR/Cas9 also efficiently catalyzes target allelemosaicism
in animals, which reflects independent gene editing eventsmade
during early embryonic cleavage stages as the totipotent zygote
undergoes pre-implantation development (Yen et al., 2014).
CRISPR/Cas9 is typically delivered into mammalian zygotes on
embryonic day (E)0.5 to E1, which is5–6 days before the germ-
line is specified in rodents. As an example, themouse germline is
specified within a small population of 10–20 proximal epiblast
cells between E6 to E6.5 (Ohinata et al., 2005). Taken together,
this explains why CRISPR/Cas9-target allele mosaicism is
observed in tissues of first-generation mutant animals and why
targeted alleles in somatic tissues can differ from those specified
in the germline. Target allele heterogeneity in mosaic animals
must be outcrossed to generate colonies of pure, non-mosaic
germline mutants isogenic for a given targeted allele in all cells
of their body (Jaenisch et al., 1981; Soriano and Jaenisch,
1986; Wilkie et al., 1986). Sorting out new mutant strains by
experimentally outcrossing allelic mosaicism takesmonths in ro-
dents but can require years in some species due to longer life cy-
cles and/or low fecundity (Niu et al., 2014; Pursel et al., 1989).
Target allele mosaicism is also generated when host embryos
are reconstituted with pluripotent stem cells genetically modified
using CRISPR/Cas9 (Wang et al., 2013). As with the early
embryo, CRISPR/Cas9 holds potential to distinctly modify multi-
ple target alleles within a stem cell clone as it divides (Wang
et al., 2013). In addition to this variation, reconstitution of wild-
type blastocysts with pluripotent donor cells further generates
‘‘chimeric’’ animals with organ systems and germlines devel-
oping frommixtures of host and donor embryonic cells (Tarkow-
ski, 1961). Mosaicism and chimerism was substantially reduced
when clonally enriched donor cells modified with CRISPR/Cas9
were used to produce pigs and goats by somatic cell nuclear
transfer into enucleated oocytes (i.e., cloning) (Ni et al., 2014).
Reconstituting tetraploid embryos with pre-screened, clonally
expanded pluripotent lines would also be predicted to minimize
mosaicism and chimerism in epiblast-derived tissues (Nagy
et al., 1990). Alternatively, direct germline editing in donors
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Figure 1. CRISPR/Cas9-Mediated Gene
Targeting in Donor Stem Spermatogonia
(A) CRISPR/Cas9 cleavage of Epsti1 in rat fibro-
blast and spermatogonial (Sg day 11) cultures
on day 11 post-transfection and in flow-sorted
EGFP+ spermatogenic cells (R1661) on day 56
after transplantation into the right testis of recipient
R1661:  and + symbols indicate transfection
without and with Epsti1 gRNA. Arrows indicate
predicted 461 base pairs (bp) plus 226 bp
Surveyor products.
(B) Spermatogenesis (green fluorescence) in testis
of R1661 on day 56 after transplantation that
developed from donor EGFP+ rat spermatogonial
cultures containing CRISPR/Cas9-catalyzed Ep-
sti1 mutations.
(C) Targeted mutagenesis of Epsti1 exon 2 in
rats by CRISPR/Cas9 spermatogonial gene edit-
ing. Donor spermatogonia were hemizygous for
tgGCS-EGFP. DTB, days from transplantation to
first litter containing Epsti1 mutant animals; FS,
frame shift mutation; IF, mutation in frame. yR(n),
recipient identifier, ǁlitters born 99–128 days post-
transplantation,%, percentage of total F1 progeny
per recipient; +average value.
(D) Donor germline chimerism (%) in wild-type
recipient rat testes. Ratio of seminiferous tubules
containing EGFP+ elongating spermatids/total tu-
bules containing elongating spermatids plotted/
donor culture condition (minus selection and G418
selected). Error bars indicate SD.
(E) Acrosome (PNA) and nuclear (Hoechst 33342)
labeling marking donor-derived elongating sper-
matids (EGFP+) in tubule cross-sections from
recipient R1659 and R1662. Left: 39 of 39 tubules
contained elongating spermatids (EGFP+ or
EGFP). Five EGFP tubules are marked with an
asterisk. Scale bar, 500 mm. Right: higher magni-
fication image of donor spermatogenesis at stages
VIII and XI in the rat seminiferous epithelial cycle
(Hess, 1990). Scale bar, 100 mm.
See also Figures S1 and S2 and Tables S1 and S2.spermatogonial stem cells would avoid both the totipotent and
pluripotent states of embryogenesis (Brinster and Avarbock,
1994), thus eliminating production of mosaic/chimeric mutant
progeny. Here, we report efficient production of mutant rats by
spermatogonial gene editing with CRISPR/Cas9.
RESULTS
Spermatogonial gene editing at Epsti1 loci was conducted using
CRISPR/Cas9 as proof of concept for efficient gene targeting in
rats. Epsti1 encodes epithelial-stromal interaction, and Epsti1
variants in men are associated with alterations in sperm function
and family size (Kosova et al., 2012). Guide RNAs demonstrating
highest specificity to exon 2 of rat Epsti1 in silico were first testedCell Reports 10, 1828–1835for activity in rat fibroblast cultures (Fig-
ure 1A). A plasmid encoding an effective
Epsti1 gRNA and Cas9 (pgEpsti1-330)
was transfected (neon electroporation)
into rat spermatogonia hemizygous for agermline-specific Egfp marker (Cronkhite et al., 2005), with and
without a second plasmid encoding a selectable marker
(pNeoDtk) (Hamra et al., 2005). Spermatogonia from each trans-
fection, with and without pNeoDtk, were plated onto fibroblast
feeder layers and selected with and without G418 in growth me-
dium (days 3–9). Spermatogonia were then sub-cultured for two
passages (days 11 and 23) (Chapman et al., 2011) and trans-
planted into rat seminiferous tubules (day 34) (Figure 1B). Pre-
dicted cleavage of targeted Epsti1 alleles in donor germlines
by the Surveyor assay was similar in spermatogonial cultures
harvested at day 11 post-transfection (9% insertions or dele-
tions [indels]) and in the total population of flow-sorted EGFP+
spermatogenic cells produced in recipient R1661 by day 56
post-transplantation (10% indels) (Figure 1A). This provided, March 24, 2015 ª2015 The Authors 1829
evidence that CRISPR/Cas9-dependent modifications to Epsti1
were maintained in stem cells during sub-culture and persisted
during spermatogenesis in recipient rats.
Based on robust colonization by stably modified donor
spermatogonia in R1661 (Figures 1A and 1B), four remaining
recipient rats (n = 2 transplanted with G418 selected cells
and 2 transplanted with unselected cells) were paired with
wild-type females at 65 days post-transplantation until
each pair produced two litters (n = 8 total litters) (Figure 1C).
F1 progeny harbored 10% total Epsti1 mutants (n = 9/87
F1 pups) within an estimated 87% donor-derived progeny
(38 EGFP+/87 F1 pups = 43.6% 3 2; hemizygous marker)
(Figure 1C). Spermatogonia selected in G418-containing me-
dium yielded 33 more mutant progeny than spermatogonia
from unselected cultures (5% mutants, minus selection; 15%
mutants, G418 selected) (Figure 1C). Fifty-six percent of
Epsti1 mutations in progeny were frame shifts (five of nine)
(Figures 1C and S1A). The remaining Epsti1 variants (four of
nine) were in-frame deletions (Figures 1C and S1A). Thus, cul-
tures of CRISPR/Cas9-mutagenized spermatogonial stem
cells were successfully applied to produce pure Epsti1 mutant
rats 100 days post-transplantation (101.5 ± 2.1 days; n = 4
recipients) (Figure 1C).
Histological analysis of recipient testes at day 178 post-trans-
plantation revealed robust spermatogenic potential of donor
stem cells under each culture condition tested (Figures 1D and
1E). Most seminiferous tubules in recipients contained EGFP+
elongating spermatids (65.5 ± 14%, minus selection; 79 ±
17%, G418 selected; n = 4 testes from two rats per culture con-
dition, 117–176 tubules scored per testis) (Figure 1D; Table S1).
Crosses between recipient male and wild-type female rats pro-
duced normal-sized litters (10.9 ± 3.4 pups per litter, n = 8)
(http://www.harlan.com), with testes at approximately half the
normal weight (Table S2) but approximately three times heavier
than reported for non-transplanted, busulfan-treated testes
(Hamra et al., 2002). EGFP+ germ cells flow-sorted from recipient
rat testes (Figure S2) revealed 5% (1/20 amplicons) and 36%
(8/22 amplicons) distinct mutant Epsti1 alleles derived from un-
selected and G418-selected spermatogonia, respectively (Fig-
ure S1B). Thus, intra-recipient donor haplotype frequencies
were consistent with germline transmission rates for Epsti1 mu-
tations (Figure 1C; Table S1).
Although non-mosaic mutant rat strains were efficiently
generated by spermatogonial gene editing with CRISPR/
Cas9, the targeted Epsti1 alleles varied considerably between
strains (Figure S1). This appeared as random repair of
cleaved template in distinct donor stem cells. Monoclonal
enrichment of donor spermatogonial stem cells in culture
following genome editing with CRISPR/Cas9 would, theoreti-
cally, reduce variation of targeted alleles transmitted to
progeny by recipients. Clonal enrichment of CRISPR/Cas9-
modified stem spermatogonia in culture prior to transplanta-
tion would also facilitate studying the effects of recessive
mutations on spermatogenesis (particularly, in cases of
embryonic lethality). As an example, Erbb3 is critical for
embryogenesis in mice (Erickson et al., 1997) and encodes a
receptor tyrosine kinase activated by the polypeptide ligand
NRG1 (Carraway et al., 1994). Furthermore, NRG1, GDNF,1830 Cell Reports 10, 1828–1835, March 24, 2015 ª2015 The Authorand serum were required for the clonal development of differ-
entiating spermatogenic cells in vitro on laminin (Hamra et al.,
2007). To define a germline receptor for NRG1 in rats,
we analyzed CRISPR/Cas9-targeted Erbb3 mutations in sper-
matogonial stem cell lines derived from individually picked col-
onies (Figure 2A).
Six of 26 picked colonies analyzed (23%) were enriched
with targeted Erbb3 mutations after clonal expansion on fibro-
blast feeder layers (Figure 2A and Figure S3A). It is interesting
that all six mutant colonies were classified as harboring iso-
genic (three of six colonies) or heterogeneous (three of six col-
onies) biallelic targeted mutations (Figure S3A). Mutant colonies
with isogenic targeted alleles (i.e., B9, C7, D3) were, initially,
falsely classified as wild-type germlines by the Surveyor assay
(Figure S3B) but subsequently defined as biallelic Erbb3
mutant germlines by sequencing (Figures S3A and S3B). This
is consistent with the Surveyor assay becoming less accurate
at estimating percent modified alleles as target allele variation
decreases (Guschin et al., 2010).
Biallelic mutant spermatogonial lines derived from picked
colonies were deficient in ERBB3 (Figure 2B) and proliferated
at similar rates over multiple passages in culture compared to
clonally expanded wild-type lines (Figure 2C). Unlike wild-
type lines, six of six clonally enriched Erbb3-deficient germ-
lines were severely compromised in their ability to support
development of ZBTB16 spermatogenic colonies in culture
on laminin in a serum-free, spermatogonial differentiation
medium (SD medium) supplemented with NRG1, GDNF,
FGF2, and all-trans-retinoic acid (Figures 2D and 2E). All
wild-type germlines picked from the same transfection effec-
tively developed into syncytia containing 8–32 differentiating
spermatogenic cells negative for ZBTB16 labeling (tgGCS-
EGFP+, ZBTB16; n = 5 lines) (Figures 2D and 2E). ZBTB16
(or PLZF) is a marker for type A spermatogonia in mammalian
testes and is critical for spermatogonial stem cell self-renewal
in mice (Buaas et al., 2004; Costoya et al., 2004). In contrast
to their in vitro phenotypes, Erbb3-deficient spermatogonial
lines (B9 and C7) robustly regenerated spermatogenesis in
recipient rats when analyzed 2.5–3.5 months post-transplan-
tation (Figure 3A; Figure S4A). Thus, the ability of Erbb3-defi-
cient germlines to regenerate spermatogenesis in recipient
testes did not reflect NRG1’s requirement for clonal develop-
ment of differentiating spermatogenic cells in culture (Figures
2D and 2E).
To assess the sperm-forming potential of Erbb3-deficient
spermatogonial lines longer term, recipients of clonally expanded
lines C7 (R1697) and C8 (R1699) were paired with wild-type
females at day 207 post-transplantation (6.8 months; both
testes transplanted per recipient). The recipient of line C8 was
highly enriched with +C and DC frame shift mutations (Figures
S3A and S3B) and fathered progeny inheriting each Erbb3 germ-
linemutation (46%of progenywere +CorDC targeted alleles; 6
of 13 pups) (Figure 3B; Figure S3C). All Egfp+ pups (five of five)
harbored one of the two targeted alleles (Figure 3B; Figures
S3C and S3D), consistent with colony C8 representing a homo-
geneous biallelic mutant germline (Figures S3A and S3B). Simi-
larly, the recipient of isogenic lineC7 (enrichedwith+C frameshift
mutations; FiguresS3A andS3B) fathered a litter of ten pups, fours
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Figure 2. Monoclonal Enrichment of Erbb3-
Deficient Stem Spermatogonia
(A) CRISPR/Cas9-targeted Erbb3mutations (exon
2) in clonally expanded rat spermatogonial lines.
(B) Relative abundance of ERBB3 (upper arrow-
head) and TUBA1a (lower arrowhead) in wild-type
(colony D4; WT) and Erbb3-deficient (colony B9;
KO) spermatogonial lines.
(C) Left: cultures of clonally expanded wild-type
(colony D4) and Erbb3 knockout (colony B9)
spermatogonia expressing tgGCS-EGFP. Right:
Growth rates of clonally expanded wild-type (WT)
and Erbb3 knockout (KO) spermatogonial lines.
Scale bars, 50 mm.
(D) NRG1-dependent development of differenti-
ating spermatogenic cells from wild-type and
Erbb3 knockout spermatogonial lines. Error bars
indicate SD.
(E) Spermatogenic cells from colonies D4 (wild-
type) and B9 (Erbb3 knockout) analyzed in (D).
tgGCS-EGFP is indicated in green, and ZBTB16
antibody is indicated in red. IgG, immunoglobulin
G. Scale bars, 40 mm.
See also Figure S3.of which inherited the +C mutation in Erbb3 (Figure S3C). Again,
all Egfp+ pups (three of three) harbored the targeted Erbb3 allele
(Figures S3C and S3D), which would be expected in progeny
derived from a monoclonal donor germline harboring two tar-
geted Erbb3 alleles.
Analysis of recipient testes at day 239 post-transplantation
(7.8 months) revealed donor-derived spermatogenesis from
lines C7 and C8 (Figure S4B) but at visibly reduced levels of
colonization compared to wild-type germlines (Figure 3C).
Neither recipient testis weights (Figure 3D) nor the percent
seminiferous tubules containing both EGFP+ type A spermato-
gonia (ZBTB16+) and spermatids (PNA+) were significantly
different between recipients of wild-type and Erbb3 mutant
germlines (Figure S4B). Donor-derived spermatids were pre-
sent in >90% of seminiferous tubule sections colonized by
EGFP+ spermatogenic cells, independent of the clonal line
transplanted (n = 3 wild-type lines and 3 biallelic mutant lines)
(Figure S4B).Cell Reports 10, 1828–1835DISCUSSION
Here, we demonstrate how CRISPR/
Cas9-mediated germline editing in donor
spermatogonia can be used to produce
‘‘pure,’’ non-mosaic mutant animals and
to study the effects of gene mutations
on spermatogenesis. In doing so, we
provide proof of concept for targeted
mutagenesis directly in fully functional
rat donor germlines. This included poly-
clonal and monoclonal enrichment of
rat spermatogonial lines harboring herita-
ble, CRISPR/Cas9-targeted alleles. High
colonization efficiency (Hamra et al.,
2005; Wu et al., 2009), transfection effi-
ciency, and sperm-forming potential of donor germlines trans-
lated into robust mutant rat production by spermatogonial
gene editing with CRISPR/Cas9.
An estimated 15%–30% of donor-cell-derived progeny was
obtained by breeding recipients transplanted with G418-sel-
ected donor spermatogonia (200,000 per testis) carrying tar-
geted Epsti1 alleles (Figure 1C). Similarly, 43% of pups (10/
23, n = 2 litters, 1 litter per donor strain) were derived frommono-
clonally enriched donor spermatogonial lines (60,000 per testis)
harboring Erbb3 null mutations (Figure 3B; Figure S3). Actual
transmission rates from targeted germlines would be contingent
on how mutated alleles affect sperm development or function
and on rates at which biallelic null mutations were generated
and maintained per transfected sperm-forming spermatogo-
nium. In the two examples reported here, even if Epsti1 or
Erbb3 was found essential for male fertility, the phenotypically
diploid nature of clonally derived spermatids imparted by ring
canals (Braun et al., 1989; Wilkie et al., 1991) would enable, March 24, 2015 ª2015 The Authors 1831
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Figure 3. Transmission of Isogenic CRISPR/
Cas9-Targeted Alleles to Rat Progeny
(A) Top: spermatogenesis (green) derived from
wild-type (WT) colony D4 and Erbb3 knockout (KO)
colony B9 in testes from R1683 at 3.5 months
post-transplantation. Scale bar, 1 cm. Bottom:
seminiferous tubule cross-section from R1683
illustrating spermatogenesis derived from colony
B9 marked by EGFP (green). ZBTB16+ spermato-
gonia are indicated by red nuclei. Scale bar,
100 mm.
(B) Genotypes of rat progeny derived from clonally
expanded spermatogonial line C8. tgGCS-EGFP is
a hemizygous marker.
(C) Recipient rat testes 7.8 months post-trans-
plantation. Clonally expanded lines were trans-
planted into the right testes of R1686, R1702, and
R1700 (EGFP+), but contralateral left testes were
not transplanted. Note that the right and left testes
of R1697 were transplanted. Scale bar, 1 cm.
(D) Mean testis weights from recipient rats analyzed
7.8 months after transplanting with wild-type
(WT) spermatogonial lines (D4, n = 2; B11, n = 3; A6,
n = 2) and Erbb3-deficient (KO) spermatogonial
lines (B9, n = 2; C7, n = 3; C8, n = 3). NT, un-
transplanted testes, n = 11 (error bars indicate SD;
p values are frommultiple t tests). The ns are shown
in parentheses above the bars.
See also Figures S3 and S4.spermatogonial stem cells containing at least one functional
copy of the targeted allele (wild-type or in-framemutant) to verti-
cally transmit recessive loss-of-function donor haplotypes.
Here, monoclonally enriched spermatogonial lines harboring
biallelic, CRISPR/Cas9-targeted Erbb3 null mutations were also
applied to study spermatogenesis during culture in vitro and in
recipient rat testes (Figures 2 and 3). Notably, the Erbb3-deficient
germlines were analyzed in vitro using highly simplified, serum-
free culture media that effectively promoted spermatogonial
stem cell renewal (SG medium) or differentiation (SD medium)
(Figure 2). Unknown factors in recipient testes, whichwere appar-
ently absent or inactive in vitro, were sufficient to support sper-
matogonial differentiation on the Erbb3-deficient background.
Looking ahead, the ability to ‘‘multiplex’’ with CRISPR/Cas9 holds
the potential to study such redundant or polygenic processes
contributing to the genetic robustness of spermatogenesis (Arch-
ambeault and Matzuk, 2014). Thus, recessive genetic assays in
fully functional rat spermatogonial stem cells were established
by these studies, providing an experimental platform to biochem-
ically and genetically define in vitro spermatogenesis-stimulating
factors, such as NRG1 and ERBB3.
Based on the germline transmission rates of targetedEpsti1 al-
leles that we obtained by breeding recipient rats (Figure 1), trans-
planting spermatogonial stem cells into seminiferous tubules1832 Cell Reports 10, 1828–1835, March 24, 2015 ª2015 The Authorsmore directly after delivering CRISPR/
Cas9 constructs than in the current study
holds a clear potential to expedite produc-
tion of pure mutant rat strains by up to an
additional month (Figure 4). Spermatogo-
nial geneediting usingCRISPR/Cas9 tech-
nology can readily be adopted in rodents on a scalable level
(Izsva´k et al., 2010; Kanatsu-Shinohara et al., 2005; Nagano
et al., 2001a) and could be established to streamline puremutant
animal production in other applied species important for science,
industry, conservation, and medicine (Arregui et al., 2013; Her-
mann et al., 2012; Nagano et al., 2001b; Zeng et al., 2013).
Indeed, proof of concept for correcting genetic disease in mice
by spermatogonial gene editingwithCRISPR/Cas9was reported
during the revision of this article (Wu et al., 2015).
EXPERIMENTAL PROCEDURES
Spermatogonial Gene Editing with CRISPR/Cas9
Spermatogonial lines were derived from freshly isolated laminin-binding
spermatogonia using individual heterozygous SD-Tg(ROSA-EGFP)2-4Reh rats
(Hamra et al., 2005). SD-Tg(ROSA-EGFP)2-4Reh Sprague-Dawley rats are
referred to as tgGCS-EGFP rats because they exhibit germ-cell-specific expres-
sion of EGFP (Cronkhite et al., 2005). Spermatogonial lines were propagated on
feeder layers of irradiated mouse embryonic fibroblasts (MEFs) as previously
detailed using SG medium containing 6 ng/ml basic fibroblast growth factor
(bFGF) (PGF0023, Life Technologies) and 6 ng/ml GDNF (512-GF, R&D Sys-
tems) (Chapman et al., 2011;Wu et al., 2009). To generate Epsti1mutants, sper-
matogonia were harvested at passage 8 and co-transfected in suspension with
plasmids pNeoDtk and/or pX330 (Cong et al., 2013) using theNeonTransfection
System (Life Technologies) set for two pulses at 1,100 V, 20 ms. pX330 co-ex-
pressed Cas9 and gRNAs 50-tgatagcaccgaacgagacc-30 (pgEpsti1-330; cloned
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Figure 4. CRISPR/Cas9 Gene Targeting in
Early Embryos and Spermatogonia
Left: zygotes are injected with CRISPR/Cas9
constructs and transferred into surrogate female
oviducts to support donor embryo development
into mutant progeny. Mosaic mutant progeny born
19–22 days (d) post-transfer (depending on
cleavage stage transferred) (superscript 1) display
variation in targeted alleles in various tissues and
must be crossed to wild-type stock to generate
pure heterozygous mutants isogenic at respective
targeted alleles in all cells of their body.
Center: rat pluripotent stem cell cultures could
prospectively be genetically modified using
CRISPR/Cas9. Rat embryonic stem cells with
targeted mutations have been selected in culture
prior to blastocyst injection (Tong et al., 2011).
Injected blastocysts are transferred into uteri of
surrogate females to produce mosaic/chimeric
mutant animals 19 days post-transfer (super-
script 1). Mosaic/chimeric animals are crossed to
wild-type stock to establish pure heterozygous
mutants.
Right: spermatogonial stem cells can be geneti-
cally modified in culture using CRISPR/Cas9.
Modified spermatogonia are injected into recipient
rat testes to produce mutant spermatozoa that
transmit targeted genomic modifications to het-
erozygous mutant progeny. Timelines for each
approach listed above must consider75 days for
rat breeder pairs to reach reproductive age, 21–
23 days for rat gestation time, plus a 4- to 5-day
estrus cycle in rats (Lohmiller and Swing, 2006)
(superscript 2).
*Includes additional 4 days to establish pseudo-pregnant female recipients by paring with vasectomized males; does not include time needed to prepare
vasectomized male rats. **Remains to be determined (t.b.d) using CRISPR/Cas9; estimate based on rat embryonic stem cell lines selected following transfection
with classical DNA targeting constructs (Tong et al., 2011); includes an additional 4 days to establish pseudo-pregnant female recipients. ***Present study;
minimum time required following delivery of CRISPR/CAS9 constructs to spermatogonia (with or without genetic selection) prior to transplantation was not
studied and remains to be determined (t.b.d); includes 12 days to prepare recipient males.intoBbsI sites). pNeoDtkwas generated from parental plasmid, pKO1904 (Stra-
tagene), by excising its thymidine kinase cassette and retaining the neomycin
phosphotransferase open reading frame under control of the PGK1 promoter.
Cultures not undergoing G418 selection were transfected using 10 mg pgEp-
sti1-330/106 spermatogonia; cultures undergoing G418 selection were co-
transfected using3 mg pgEpsti1-330+7 mg pNeoDtk/106 spermatogonia. Trans-
fected spermatogonia for each respective condition were plated onto fresh
MEFs for 3 days (day 3) and selected in SG medium containing 0 or 65 mg/ml
G418 for 6 days (day 9) prior to harvesting and plating on fresh MEFs in SGme-
dium on day 11 (Chapman et al., 2011). To generate clonally enriched Erbb3-
deficient germlines, spermatogonial stem cells from passage 6 were similarly
transfected with pgErbb3-330 (gRNA 50-ggggaacccaggtctacgat-30) and diluted
post-transfection by plating an equivalent of 7.5 3 104 to 1.5 3 105 cells/
9.5 cm2 in SG medium to promote picking individual colonies for derivation of
clonally enriched spermatogonial lines, as described elsewhere in detail
(Chapman et al., 2011; Ivics et al., 2011; Izsva´k et al., 2010). Individually picked
colonies required a mean (± SD) of 81 ± 20 and 89 ± 21 days to expand wild-
type (n = 5) and Erbb3-deficient (n = 6) spermatogonial lines to 2 3 105 cells,
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